Low Risk Is Low Risk: iNAAN Post Hoc Analysis of Phenotypic Predictors of Penicillin Direct Oral Challenge Safety.
Saved in:
| Title: | Low Risk Is Low Risk: iNAAN Post Hoc Analysis of Phenotypic Predictors of Penicillin Direct Oral Challenge Safety. |
|---|---|
| Authors: | Mitri EA; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Melbourne, Victoria, Australia.; National Allergy Centre for Excellence, Parkville, Victoria, Australia., Vogrin S; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Melbourne, Victoria, Australia., Peter JG; Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa.; Division of Allergology and Clinical Immunology, Department of Medicine, Faculty of Health Sciences, Groote Schuur Hospital, Cape Town, South Africa., Li PH; Division of Rheumatology and Clinical Immunology, Department of Medicine, The University of Hong Kong, Pok Fu Lam, Hong Kong., Copaescu AM; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia.; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre, Quebec, Canada., Day C; Allergy and Immunology Unit, University of Cape Town Lung Institute, Cape Town, South Africa.; Division of Allergology and Clinical Immunology, Department of Medicine, Faculty of Health Sciences, Groote Schuur Hospital, Cape Town, South Africa., Goh M; Department of Dermatology, Austin Health, Heidelberg, Victoria, Australia.; Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia., Belmont AP; Section of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA., Fernando SL; Department of Clinical Immunology and Allergy, Royal North Shore Hospital, Sydney, New South Wales, Australia.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia., Trubiano JA; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases and Immunology, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity at the University of Melbourne, Melbourne, Victoria, Australia.; National Allergy Centre for Excellence, Parkville, Victoria, Australia. |
| Corporate Authors: | International Network of Antibiotic Allergy Nations (iNAAN) study group |
| Source: | Allergy [Allergy] 2026 Jun 12. Date of Electronic Publication: 2026 Jun 12. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: Denmark NLM ID: 7804028 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1398-9995 (Electronic) Linking ISSN: 01054538 NLM ISO Abbreviation: Allergy Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
